We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXE icon
1301
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$4.08M 0.01%
41,300
+39,336
+2,003% +$3.71M
KLAC icon
1302
KLA
KLAC
$266B
$4.07M 0.01%
107,910
-303,090
-74% -$10.6M
NAPA
1303
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$4.07M 0.01%
245,426
-99,781
-29% -$1.53M
GRNT.WS
1304
CALL
DELISTED
Granite Ridge Resources, Inc. Warrants to purchase Common Stock, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
GRNT.WS
$4.06M 0.01%
+449,965
New +$479K
WAVC
1305
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
$4.06M 0.01%
405,285
MDAIW icon
1306
CALL
Spectral AI Warrants
MDAIW
$5.9M
$4.04M 0.01%
385,000
DNZ.WS
1307
CALL
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$4.04M 0.01%
404,237
NVRO
1308
DELISTED
NEVRO CORP.
NVRO
$4.04M 0.01%
101,962
-84,349
-45% -$3.51M
AGGRW
1309
CALL
DELISTED
Agile Growth Corp Warrant
AGGRW
$4.04M 0.01%
399,997
CPAY icon
1310
Corpay
CPAY
$24.8B
$4.02M 0.01%
21,893
+14,111
+181% +$2.58M
SPCM
1311
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$4.02M 0.01%
369,798
BLEUR
1312
CALL
DELISTED
bleuacacia ltd Rights
BLEUR
$4.02M 0.01%
400,000
BLEU
1313
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
$4.02M 0.01%
400,000
EPAC icon
1314
Enerpac Tool Group
EPAC
$1.78B
$4.02M 0.01%
+157,769
New +$3.8M
GLOB icon
1315
Globant
GLOB
$1.41B
$4.01M 0.01%
23,867
+22,167
+1,304% +$3.92M
INTU icon
1316
PUT
Intuit
INTU
$83.1B
$4.01M 0.01%
10,300
+800
+8% +$317K
GTE icon
1317
Gran Tierra Energy
GTE
$238M
$4M 0.01%
404,481
+29,432
+8% +$346K
KCGI.WS
1318
CALL
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$4M 0.01%
392,492
ASTS icon
1319
AST SpaceMobile
ASTS
$17.4B
$4M 0.01%
+830,333
New +$5.01M
BSBR icon
1320
Santander
BSBR
$40.7B
$4M 0.01%
742,187
-374,937
-34% -$2.05M
TWOU
1321
DELISTED
2U Inc
TWOU
$4M 0.01%
+21,267
New +$4.22M
THACW
1322
CALL
DELISTED
Thrive Acquisition Corporation Warrant
THACW
$3.99M 0.01%
385,474
ZPTAW
1323
CALL
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$3.99M 0.01%
386,207
AHRNW
1324
CALL
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
$3.96M 0.01%
384,898
TDG icon
1325
TransDigm Group
TDG
$71.9B
$3.95M 0.01%
6,276
-42,975
-87% -$25.3M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.